Press Releases
- Oct 6, 2016-- Substantive pre-IND meeting with FDA provides clarity for clinical pathway of the Company's novel Cellspan Esophageal Implant --
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Sep 29, 2016- Presentation on Thursday, October 6th at 3:15 p.m. PT -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Sep 14, 2016- Presentation with Live Webcast on Wednesday, September 21 at 11:30 a.m. PT -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Aug 24, 2016- Presentation with Live Webcast on Monday, September 12 at 3:00 p.m. EDT -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Aug 22, 2016- Recipient of NI Engineering Impact Award for Advanced Research in Regenerating and Restoring Organ Function Damaged by Disease or Trauma -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
